Recent Finacing
Recent Raise
Celsius uses its SCOPE platform—clinically annotated human tissue, single-cell RNA sequencing, and machine learning—to identify therapeutic targets, biomarkers, and patient stratification hypotheses for autoimmune diseases and cancer.
